Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Do B12 deficiency, folate deficiency, metformin, hypochlorhydria, and methylation-related variants together impair one-carbon metabolism?

These factors can converge to impair one-carbon metabolism more than any single factor alone.

PlausibleJuly 27, 202621 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

B12 deficiency, folate deficiency, metformin exposure, hypochlorhydria, and methylation-related genetic variants can converge to impair one-carbon metabolism more than any single factor alone.

laying out figure…
6 of 9 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that B12 deficiency, folate deficiency, metformin exposure, hypochlorhydria, and methylation-related genetic variants can combine into a stronger metabolic block than any one factor by itself. The mechanism framing emphasizes overlapping effects on vitamin B12 absorption, folate availability, and one-carbon enzymatic flux, creating a compounded bottleneck in methylation pathways. It also notes that this convergence can extend toward downstream neurological consequences.

Verified conclusion

One-carbon metabolism relies on a highly integrated network of micronutrient cofactors, absorption pathways, and enzymatic regulators. When multiple environmental, pharmacological, and genetic stressors align, they create a compounding metabolic blockade that exceeds the impact of any single factor.

Biochemical mechanisms of convergence

  • The Methyl-Trap and Genetic Compromise: Vitamin B12 is a mandatory cofactor for methionine synthase. Deficiency in B12 reduces enzyme activity, halting the remethylation of homocysteine to methionine and biochemically trapping folate as 5-methyltetrahydrofolate (5-MTHF). This functional folate deficiency is further exacerbated by polymorphisms in MTRR and MTHFD1, which decrease enzymatic efficiency, and TCN2 variants, which impair cellular B12 transport.
  • Metformin's Direct Pathway Interference: Beyond blocking absorption, metformin directly impairs folate pathways via independent, antifolate-like activity. This action traps folate cofactors, such as 5-formimino-THF, directly hindering one-carbon and folate flux.

Absorption-related and clinical disruptions

  • The Malabsorption "Double Hit": Hypochlorhydria impairs the gastric acid- and pepsin-mediated cleavage of food-bound B12. Concurrently, chronic metformin therapy—associated with reduced B12 levels in 10% to 30% of users—interferes with the calcium-dependent absorption of the intrinsic factor-B12 complex in the terminal ileum.
  • Neurological Consequences: The resulting profound reduction in methyl donor availability and the accumulation of methylmalonic acid and homocysteine severely compromise methylation pathways, directly driving or compounding peripheral neuropathy.

Bottom line

  • While individual genetic or environmental factors mildly perturb methylation, the convergence of gastric hypochlorhydria, metformin exposure (which impairs both B12 absorption and folate flux), and genetic variants (MTRR, TCN2, MTHFD1) creates a synergistic metabolic bottleneck that severely disrupts one-carbon metabolism.

References

  1. Interaction between Metformin, Folate and Vitamin B12 and ... — pdfs.semanticscholar.org ↗
  2. Can I Take Folate with Metformin? - HealthRX.com — healthrx.com ↗
  3. Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users — pmc.ncbi.nlm.nih.gov ↗
  4. Metformin-induced vitamin B12 deficiency can cause or ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  5. Association between metformin and vitamin B12 deficiency in ... — pmc.ncbi.nlm.nih.gov ↗
  6. Metformin and reduced vitamin B12 levels: new advice for ... — gov.uk ↗
  7. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind — pmc.ncbi.nlm.nih.gov ↗
  8. Vitamin B12 Deficiency in Patients Taking Metformin: Pathogenesis and Recommendations — pmc.ncbi.nlm.nih.gov ↗
  9. Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus — pmc.ncbi.nlm.nih.gov ↗
  10. Use of Metformin Is a Cause of Vitamin B12 Deficiency — aafp.org ↗
  11. Prevalence of Vitamin B12 Deficiency in Type 2 Diabetes Mellitus Patients on Metformin Therapy — assets.cureus.com ↗
  12. Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels? — pmc.ncbi.nlm.nih.gov ↗
  13. Vitamin B12 Deficiency Associated With Concomitant Metformin and Proton Pump Inhibitor Use — pmc.ncbi.nlm.nih.gov ↗
  14. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial — pmc.ncbi.nlm.nih.gov ↗
  15. Relationship between metformin use, vitamin B12 deficiency ... — pubmed.ncbi.nlm.nih.gov ↗
  16. Effects of short-term treatment with metformin on serum ... — pubmed.ncbi.nlm.nih.gov ↗
  17. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial — bmj.com ↗
  18. Metabolomic fingerprint reveals that metformin impairs one-carbon ... — pmc.ncbi.nlm.nih.gov ↗
  19. Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus — cureus.com ↗
  20. Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy — pmc.ncbi.nlm.nih.gov ↗
  21. Association of metformin, elevated homocysteine, and ... — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→